CLINICAL_TRIALS
withdrawal
· 2024-01-29
Clinical Trial Update: Retroviral Insertion Site Methodology Study [Phase 4]
Summary
A Phase 4 clinical trial investigating retroviral insertion site methodology for immune system diseases was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fondazione Telethon | Conditions: Immune System Diseases | Phase 4 | Status: WITHDRAWN